Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2022-12-12 00:00:00 ET · period of report 2022-12-09 · accession 0001628280-22-031725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-12 | 2022-12-09 | AVTX | NEIL GARRY ARTHUR | CEO, COB, Dir | P - Purchase | $4.42 | +2,083 | 9,220 | +29% | +$9,207 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | P | A | 2,083 | $4.42 | 9,220 | D | — | — | (F1) These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan. |